Morningstar
•
Oct 21, 2026
Cencora, Inc.: Cencora: Doubles Down on Oncology With AON Acquisition; Fair Value Estimate Maintained
Summary
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Market Update: CB, F, FLEX, ISRG, TSCO, VZ
Oct 30, 2026
•
VZ, F, FLEX, TSCO, ISRG, CB
Analyst Report: Verizon Communications Inc
Oct 30, 2026
•
VZ
Analyst Report: Digital Realty Trust, Inc.
Oct 30, 2026
•
DLR
Analyst Report: Equinix, Inc.
Oct 29, 2026
•
EQIX
Analyst Report: West Pharmaceutical Services, Inc.
Oct 29, 2026
•
WST
